By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Alizyme PLC 

280 Cambridge Science Park
Milton Road
Cambridge    CB4 4WE  United Kingdom
Phone: 01223-423070 Fax: 01223-423818



Company News
Alizyme PLC  (AZM.L) Release: Unaudited Preliminary Results For The Year Ended 31 December 2008 3/23/2009 2:54:26 PM
Alizyme PLC  (AZM.L) Announces Headline Results from Its European Phase 3 Clinical Trial 7/24/2008 1:59:41 PM
Alizyme PLC  (AZM.L) Commencement of Phase 2 Study in the U.S. 5/20/2008 12:51:41 PM
Prometheus Laboratories Inc. Licenses COLAL-PRED(R) From Alizyme PLC  (AZM.L) 11/29/2007 8:05:51 AM
Alizyme PLC  (AZM.L) Release: Preliminary Results And Webcast Notification 2/14/2007 1:14:44 PM
UK's Alizyme PLC  (AZM.L) Shares Boosted By Phase 2 Mucositis Drug Data 3/2/2006 10:32:38 AM
Alizyme PLC  (AZM.L) Successful Phase IIb Cetilistat Trial In Obese Diabetics 12/13/2005 3:06:43 PM
Alizyme PLC  (AZM.L) Completes Recruitment For Mucositis Trials, Sees Results Feb 2006 11/22/2005 2:21:00 PM
Alizyme PLC (AZM.L) Obtains Approval For Phase III Clinical Trial Of COLAL-PRED® For The Treatment Of Ulcerative Colitis10/19/2005 5:13:01 PM
Alizyme PLC (AZM.L) The UK Based Speciality Biopharmaceutical Development Company, Today Announces That It Proposes To Raise £32.8 Million10/19/2005 5:11:08 PM